pCMV-T7-ABE8e-SpRY-HF1-P2A-EGFP (LM434) Citations (1)

Originally described in: Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy.
Alves CRR, Ha LL, Yaworski R, Sutton ER, Lazzarotto CR, Christie KA, Reilly A, Beauvais A, Doll RM, de la Cruz D, Maguire CA, Swoboda KJ, Tsai SQ, Kothary R, Kleinstiver BP Nat Biomed Eng. 2023 Dec 6. doi: 10.1038/s41551-023-01132-z. PubMed Journal

---

Articles Citing pCMV-T7-ABE8e-SpRY-HF1-P2A-EGFP (LM434)

Articles
Susceptibility to innate immune activation in genetically mediated myocarditis. Selgrade DF, Fullenkamp DE, Chychula IA, Li B, Dellefave-Castillo L, Dubash AD, Ohiri J, Monroe TO, Blancard M, Tomar G, Holgren C, Burridge PW, George AL Jr, Demonbreun AR, Puckelwartz MJ, George SA, Efimov IR, Green KJ, McNally EM. J Clin Invest. 2024 May 16;134(13):e180254. doi: 10.1172/JCI180254. PubMed

If you have published an article using this material, please email us at to have your article added to this page.